{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:43:48Z","timestamp":1778327028169,"version":"3.51.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00384-021-04021-6","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T16:10:28Z","timestamp":1633882228000},"page":"17-33","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Postoperative bleeding and venous thromboembolism in colorectal cancer patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"37","author":[{"given":"Mikkel","family":"Lundbech","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas Engel","family":"Krag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene Hjerrild","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7136-7534","authenticated-orcid":false,"given":"Anne-Mette","family":"Hvas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"issue":"8","key":"4021_CR1","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/bjc.2014.419","volume":"111","author":"R Mirnezami","year":"2014","unstructured":"Mirnezami R, Mehta AM, Chandrakumaran K, Cecil T, Moran BJ, Carr N, Verwaal VJ, Mohamed F, Mirnezami AH (2014) Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone. Br J Cancer 111(8):1500\u20131508","journal-title":"Br J Cancer"},{"issue":"8","key":"4021_CR2","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1245\/s10434-009-0487-4","volume":"16","author":"C Cao","year":"2009","unstructured":"Cao C, Yan TD, Black D, Morris DL (2009) A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 16(8):2152\u20132165","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"4021_CR3","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","volume":"15","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Bruin S, Boot H, Van Slooten G, Van Tinteren H (2008) 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15(9):2426\u20132432","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"4021_CR4","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.ejso.2005.06.002","volume":"31","author":"A Bloemendaal","year":"2005","unstructured":"Bloemendaal A, Verwaal V, Van Ruth S, Boot H, Zoetmulder F (2005) Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study. Eur J Surg Oncol 31(10):1145\u20132115","journal-title":"Eur J Surg Oncol"},{"key":"4021_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"P Sugarbaker","year":"1995","unstructured":"Sugarbaker P (1995) Peritonectomy procedures. Ann Surg 221:29\u201342","journal-title":"Ann Surg"},{"issue":"5","key":"4021_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1245\/ASO.2006.03.079","volume":"13","author":"P Sugarbaker","year":"2006","unstructured":"Sugarbaker P, Alderman R, Edwards G, Marquardt CE, Gushchin V, Esquivel J, Chang D (2006) Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol 13(5):635\u2013644","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"4021_CR7","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, Van Ruth S, De Bree E, Van Sloothen GW, Van Tinteren H, Boot H, Zoetmulder FA (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21(20):3737\u20133743","journal-title":"J Clin Oncol"},{"key":"4021_CR8","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","volume":"89","author":"D Jayne","year":"2002","unstructured":"Jayne D, Fook S, Seow-Choen F (2002) Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89:1545\u20131550","journal-title":"Br J Surg"},{"issue":"13","key":"4021_CR9","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1245\/s10434-013-3145-9","volume":"20","author":"AM Kuijpers","year":"2013","unstructured":"Kuijpers AM, Mirck B, Aalbers AG, Nienhuijs SW, De Hingh IH, Wiezer MJ, Van Ramshorst B, Van Ginkel RJ, Havenga K, Bremers AJ, De Wilt JH, Te Velde EA, Verwaal VJ (2013) Cytoreduction and HIPEC in The Netherlands: nationwide long-term outcome following the Dutch protocol. Ann Surg Oncol 20(13):4224\u20134230","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4021_CR10","first-page":"72","volume":"7","author":"J Esquivel","year":"2016","unstructured":"Esquivel J (2016) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: survival outcomes and patient selection. J Gastrointest Oncol 7(1):72\u201378","journal-title":"J Gastrointest Oncol"},{"key":"4021_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.critrevonc.2016.01.017","volume":"100","author":"D Baratti","year":"2016","unstructured":"Baratti D, Kusamura S, Pietrantonio F, Guaglio M, Niger M, Deraco M (2016) Progress in treatments for colorectal cancer peritoneal metastases during the years 2010\u20132015. A systematic review. Crit Rev Oncol Hematol 100:209\u2013222","journal-title":"Crit Rev Oncol Hematol"},{"key":"4021_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1515\/pp-2019-0006","volume":"4","author":"A Pinto","year":"2019","unstructured":"Pinto A, Pocard M (2019) Hyperthermic intraperitoneal chemotherapy with cisplatin and mitomycin c for colorectal cancer peritoneal metastases: a systematic review of the literature. Pleura Peritoneum 4:2","journal-title":"Pleura Peritoneum"},{"issue":"6","key":"4021_CR13","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.ejso.2017.01.015","volume":"43","author":"JB Delhorme","year":"2017","unstructured":"Delhorme JB, Sattler L, Severac F, Triki E, Gross I, Romain B, Rohr S, Grunebaum L, Brigand C (2017) Prognostic factors of hemorrhagic complications after oxaliplatin-based hyperthermic intraperitoneal chemotherapy: toward routine preoperative dosage of Von Willebrand Factor? Eur J Surg Oncol 43(6):1095\u20131101","journal-title":"Eur J Surg Oncol"},{"key":"4021_CR14","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.amjsurg.2019.09.017","volume":"219","author":"EW Beal","year":"2019","unstructured":"Beal EW, Ahmed A, Grotz T, Leiting J, Fournier KF, Lee AJ, Dineen S, Dessureault S, Baumgartner JM, Veerapong J, Clarke C, Strong E, Maithel SK, Zaidi MY, Patel S, Dhar V, Hendrix R, Lambert L, Johnston F, Fackche N, Raoof M, Larocca C, Ronnekleiv-Kelly S, Pokrzywa C, Pawlik TM, Abdel-Misih S, Cloyd JM (2019) Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Am J Surg 219:478\u2013483","journal-title":"Am J Surg"},{"issue":"7","key":"4021_CR15","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1245\/s10434-016-5143-1","volume":"23","author":"T Charrier","year":"2016","unstructured":"Charrier T, Passot G, Peron J, Maurice C, Gocevska S, Quenet F, Eveno C, Pocard M, Goere D, Elias D, Ortega-Deballon P, Vaudoyer D, Cotte E, Glehen O (2016) Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy with oxaliplatin increases the risk of postoperative hemorrhagic complications: analysis of predictive factors. Ann Surg Oncol 23(7):2315\u20132322","journal-title":"Ann Surg Oncol"},{"issue":"24","key":"4021_CR16","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1002\/cncr.25356","volume":"116","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, Mansvelt B, Lorimier G, Msika S, Elias D (2010) French surgical, toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1290 patients. Cancer 116(24):5608\u20135618","journal-title":"Cancer"},{"issue":"1","key":"4021_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00268-009-0206-0","volume":"34","author":"A Saxena","year":"2010","unstructured":"Saxena A, Yan TD, Morris DL (2010) A Critical evaluation of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis. World J Surg 34(1):70\u201378","journal-title":"World J Surg"},{"key":"4021_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/000313481708300212","volume":"83","author":"J Foster","year":"2017","unstructured":"Foster J, Sleightholm R, Watley D, Wahlmeier S, Patel A (2017) The efficacy of dextran-40 as a venous thromboembolism prophylaxis strategy in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Am Surg 83:134\u2013140","journal-title":"Am Surg"},{"issue":"7","key":"4021_CR19","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1245\/s10434-019-07414-8","volume":"26","author":"S Khan","year":"2019","unstructured":"Khan S, Kelly KJ, Veerapong J, Lowy AM, Baumgartner JM (2019) Incidence, risk factors, and prevention strategies for venous thromboembolism after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 26(7):2276\u20132284","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4021_CR20","first-page":"18","volume":"52","author":"K Lanuke","year":"2009","unstructured":"Lanuke K, Mack LA, Temple WJ (2009) A prospective evaluation of venous thromboembolism in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Can J Surg 52(1):18\u201322","journal-title":"Can J Surg"},{"issue":"7","key":"4021_CR21","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/jso.24746","volume":"116","author":"A Rottenstreich","year":"2017","unstructured":"Rottenstreich A, Kalish Y, Kleinstern G, Yaacov AB, Dux J, Nissan A (2017) Factors associated with thromboembolic events following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol 116(7):914\u2013920","journal-title":"J Surg Oncol"},{"issue":"5","key":"4021_CR22","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.ejso.2015.01.016","volume":"41","author":"V Vukadinovic","year":"2015","unstructured":"Vukadinovic V, Chiou JD, Morris DL (2015) Clinical features of pulmonary emboli in patients following cytoreductive surgery (peritonectomy) and hyperthermic intraperitoneal chemotherapy (HIPEC), a single centre experience. Eur J Surg Oncol 41(5):702\u2013706","journal-title":"Eur J Surg Oncol"},{"key":"4021_CR23","first-page":"11","volume":"1","author":"P Dranichnikov","year":"2021","unstructured":"Dranichnikov P, Mahteme H, Cashin PH, Graf W (2021) Coagulopathy and venous thromboembolic events following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 1:11","journal-title":"Ann Surg Oncol"},{"key":"4021_CR24","first-page":"004318","volume":"8","author":"S Felder","year":"2019","unstructured":"Felder S, Rasmussen MS, King R, Sklow B, Kwaan M, Madoff R, Jensen C (2019) Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev 8:004318","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"4021_CR25","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.ejso.2016.09.008","volume":"43","author":"C Raspe","year":"2017","unstructured":"Raspe C, Flother L, Schneider R, Bucher M, Piso P (2017) Best practice for perioperative management of patients with cytoreductive surgery and HIPEC. Eur J Surg Oncol 43(6):1013\u20131027","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"4021_CR26","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1200\/JCO.2014.59.7351","volume":"33","author":"GH Lyman","year":"2015","unstructured":"Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Somerfield MR, Falanga A (2015) American society of clinical, venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. J Clin Oncol 33(6):654\u2013656","journal-title":"J Clin Oncol"},{"issue":"12","key":"4021_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/jcm7120567","volume":"7","author":"C Yurttas","year":"2018","unstructured":"Yurttas C, Hoffmann G, Tolios A, Haen SP, Schwab M, Konigsrainer I, Konigsrainer A, Beckert S, Loffler MW (2018) Systematic review of variations in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastasis from colorectal cancer. J Clin Med 7(12):567","journal-title":"J Clin Med"},{"issue":"1","key":"4021_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/02656736.2020.1742389","volume":"37","author":"M Tuovila","year":"2020","unstructured":"Tuovila M, Erkinaro T, Takala H, Savolainen ER, Laurila P, Ohtonen P, Ala-Kokko T (2020) Hyperthermic intraperitoneal chemotherapy enhances blood coagulation perioperatively evaluated by thromboelastography: a pilot study. Int J Hyperthermia 37(1):293\u2013300","journal-title":"Int J Hyperthermia"},{"issue":"8","key":"4021_CR29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ciresp.2015.01.012","volume":"93","author":"L Falcon Arana","year":"2015","unstructured":"Falcon Arana L, Fuentes-Garcia D, Roca Calvo MJ, Hernandez-Palazon J, Gil Martinez J, Cascales Campos PA, Acosta Villegas FJ, Parrilla Paricio P (2015) Alterations in hemostasis during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis. Cir Esp 93(8):496\u2013501","journal-title":"Cir Esp"},{"issue":"7","key":"4021_CR30","doi-asserted-by":"publisher","first-page":"E1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman D (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Plos Med 6(7):E1000097","journal-title":"Plos Med"},{"issue":"2","key":"4021_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205\u2013213","journal-title":"Ann Surg"},{"issue":"3","key":"4021_CR32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"13","author":"A Trotti","year":"2003","unstructured":"Trotti A, Colevas A, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman C (2003) Ctcae V.30: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13(3):176\u2013181","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"4021_CR33","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","volume":"8","author":"S Schulman","year":"2010","unstructured":"Schulman S, Angeras U, Bergqvist D, Eriksson B, Lassen MR, Fisher WS (2010) Subcommittee on control of anticoagulation of the, T. standardization committee of the international society on, haemostasis, definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost 8(1):202\u2013204","journal-title":"J Thromb Haemost"},{"issue":"4","key":"4021_CR34","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1214\/aoms\/1177729756","volume":"21","author":"M Freeman","year":"1950","unstructured":"Freeman M, Tukey J (1950) Transformations related to the angular and the square root. Ann Math Stat 21(4):607\u2013611","journal-title":"Ann Math Stat"},{"issue":"39","key":"4021_CR35","first-page":"1","volume":"72","author":"V Nyaga","year":"2014","unstructured":"Nyaga V, Arbyn M, Aerts M (2014) Metaprop: a stata command to performmeta-analysis of binomial data. Arch Public Health 72(39):1","journal-title":"Arch Public Health"},{"key":"4021_CR36","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"J Higgins","year":"2003","unstructured":"Higgins J, Thompson S, Deeks J, Altman D (2003) Measuring inconsistency in meta-analyses. Br Med J 327:557\u2013559","journal-title":"Br Med J"},{"issue":"11","key":"4021_CR37","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539\u20131558","journal-title":"Stat Med"},{"issue":"6","key":"4021_CR38","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1177\/0272989X05282643","volume":"25","author":"AE Ades","year":"2005","unstructured":"Ades AE, Lu G, Higgins JP (2005) The interpretation of random-effects meta-analysis in decision models. Med Decis Making 25(6):646\u2013654","journal-title":"Med Decis Making"},{"issue":"Pt A","key":"4021_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","volume":"45","author":"R Dersimonian","year":"2015","unstructured":"Dersimonian R, Laird N (2015) Meta-analysis in clinical trials revisited. Contemp Clin Trials 45(Pt A):139\u2013145","journal-title":"Contemp Clin Trials"},{"issue":"11","key":"4021_CR40","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/jech-2013-203104","volume":"67","author":"JJ Barendregt","year":"2013","unstructured":"Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T (2013) Meta-analysis of prevalence. J Epidemiol Commun Health 67(11):974\u2013978","journal-title":"J Epidemiol Commun Health"},{"key":"4021_CR41","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Brit Med J 315:629\u2013634","journal-title":"Brit Med J"},{"issue":"7","key":"4021_CR42","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1097\/DCR.0000000000000149","volume":"57","author":"D Baratti","year":"2014","unstructured":"Baratti D, Kusamura S, Iusco D, Bonomi S, Grassi A, Virzi S, Leo E, Deraco M (2014) Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients. Dis Colon Rectum 57(7):858\u2013868","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"4021_CR43","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1245\/s10434-013-3442-3","volume":"21","author":"C Eveno","year":"2014","unstructured":"Eveno C, Passot G, Goere D, Soyer P, Gayat E, Glehen O, Elias D, Pocard M (2014) Bevacizumab doubles the early postoperative complication rate after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 21(6):1792\u20131800","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"4021_CR44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/jso.24290","volume":"114","author":"IS Fr\u00f8ysnes","year":"2016","unstructured":"Fr\u00f8ysnes IS, Larsen SG, Spasojevic M, Dueland S, Flatmark K (2016) Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in norway: prognostic factors and oncologic outcome in a national patient cohort. J Surg Oncol 114(2):222\u2013227","journal-title":"J Surg Oncol"},{"issue":"7","key":"4021_CR45","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1245\/s10434-019-07294-y","volume":"26","author":"J Hentzen","year":"2019","unstructured":"Hentzen J, Rovers KP, Kuipers H, Van Der Plas WY, Been LB, Hoogwater FJH, Van Ginkel RJ, Hemmer PHJ, Van Dam GM, De Hingh I, Kruijff S (2019) Impact of synchronous versus metachronous onset of colorectal peritoneal metastases on survival outcomes after cytoreductive surgery (Crs) with hyperthermic intraperitoneal chemotherapy (HIPEC): a multicenter, retrospective, observational study. Ann Surg Oncol 26(7):2210\u20132221","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"4021_CR46","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.ejso.2018.08.012","volume":"44","author":"G Lorimier","year":"2018","unstructured":"Lorimier G, Seegers V, Coudert M, Dupoiron D, Thibaudeau E, Pouplin L, Lebrec N, Dubois PY, Dumont F, Guerin-Meyer V, Capitain O, Campone M, Wernert R (2018) Prolonged perioperative thoracic epidural analgesia may improve survival after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a comparative study. Eur J Surg Oncol 44(11):1824\u20131831","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"4021_CR47","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1245\/s10434-014-4297-y","volume":"22","author":"GA Simkens","year":"2015","unstructured":"Simkens GA, Van Oudheusden TR, Luyer MD, Nienhuijs SW, Nieuwenhuijzen GA, Rutten HJ, De Hingh IH (2015) Serious postoperative complications affect early recurrence after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis. Ann Surg Oncol 22(8):2656\u20132662","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4021_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-020-1784-4","volume":"18","author":"JSM Wong","year":"2020","unstructured":"Wong JSM, Tan GHC, Chia CS, Ong J, Ng WY, Teo MCC (2020) The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 18(1):1\u20138","journal-title":"World J Surg Oncol"},{"issue":"2","key":"4021_CR49","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, Go\u00e9r\u00e9 D, Ghouti L, Pocard M, Facy O, Arvieux C, Lorimier G, Pezet D, Marchal F, Loi V, Meeus P, Juzyna B, De Forges H, Paineau J, Glehen O (2021) Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (prodige 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 22(2):256\u2013266","journal-title":"Lancet Oncol"},{"issue":"8","key":"4021_CR50","doi-asserted-by":"publisher","first-page":"903","DOI":"10.4251\/wjgo.v12.i8.903","volume":"12","author":"J Spiegelberg","year":"2020","unstructured":"Spiegelberg J, Neeff H, Holzner P, Runkel M, Fichtner-Feigl S, Glatz T (2020) Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer. World J Gastrointest Oncol 12(8):903\u2013917","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"4021_CR51","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejso.2020.07.038","volume":"47","author":"R Lo Dico","year":"2021","unstructured":"Lo Dico R, Faron M, Yonemura Y, Glehen O, Pocard M, Sardi A, H\u00fcbner M, Baratti D, Liberale G, Kartheuser A, De Hingh I, Sugarbaker P, Ceelen W, Moran B, Robella M, Quenet F, Sideris L, Goere D, Limbert M, Sammartino P, Morris D (2021) Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: results of a worldwide analysis of 565 patients from the peritoneal surface Oncology Group International (Psogi). Eur J Surg Oncol 47(1):89\u2013100","journal-title":"Eur J Surg Oncol"},{"key":"4021_CR52","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1245\/s10434-020-08843-6","volume":"27","author":"AC Gamboa","year":"2020","unstructured":"Gamboa AC, Lee RM, Turgeon M, Ahmed A, Grotz TE, Leiting JL, Fournier KF, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner J, Clarke CN, Mogal H, Patel S, Lee T, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Cloyd JM, Maithel SK, Staley CA (2020) Implications of postoperative complications on survival after cytoreductive surgery and HIPEC: a multi-institutional analysis of the U.S. HIPEC collaborative. Ann Surg Oncol 27:S117\u2013S118","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"4021_CR53","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ejso.2017.10.216","volume":"44","author":"WJ Van Eden","year":"2018","unstructured":"Van Eden WJ, Kok NFM, Woensdregt K, Huitema ADR, Boot H, Aalbers AGJ (2018) Safety of intraperitoneal mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC. Eur J Surg Oncol 44(2):220\u2013227","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"4021_CR54","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s00384-020-03702-y","volume":"35","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wu Q, Wei M, Deng X, Gu C, Wang Z (2020) Oxaliplatin versus mitomycin c in HIPEC for peritoneal metastasis from colorectal cancer: a systematic review and meta-analysis of comparative studies. Int J Colorectal Dis 35(10):1831\u20131839","journal-title":"Int J Colorectal Dis"},{"issue":"6","key":"4021_CR55","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ejso.2010.04.005","volume":"36","author":"C Pomel","year":"2010","unstructured":"Pomel C, Ferron G, Lorimier G, Rey A, Lhomme C, Classe JM, Bereder JM, Quenet F, Meeus P, Marchal F, Morice P, Elias D (2010) Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase ii prospective multicentre trial. Chipovac Study. Eur J Surg Oncol 36(6):589\u2013593","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"4021_CR56","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ejso.2018.10.542","volume":"45","author":"W Ceelen","year":"2019","unstructured":"Ceelen W (2019) HIPEC with oxaliplatin for colorectal peritoneal metastasis: the end of the road? Eur J Surg Oncol 45(3):400\u2013402","journal-title":"Eur J Surg Oncol"},{"issue":"13","key":"4021_CR57","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1245\/s10434-020-08330-y","volume":"27","author":"RJ Torphy","year":"2020","unstructured":"Torphy RJ, Stewart C, Sharma P, Halpern AL, Oase K, Herter W, Bartsch C, Friedman C, Del Chiaro M, Schulick RD, Gleisner A, Mccarter MD, Ahrendt SA (2020) Dextrose-containing carrier solution for hyperthermic intraperitoneal chemotherapy: increased intraoperative hyperglycemia and postoperative complications. Ann Surg Oncol 27(13):4874\u20134882","journal-title":"Ann Surg Oncol"},{"key":"4021_CR58","first-page":"610597","volume":"2015","author":"E Halkia","year":"2015","unstructured":"Halkia E, Tsochrinis A, Vassiliadou DT, Pavlakou A, Vaxevanidou A, Datsis A, Efstathiou E, Spiliotis J (2015) Peritoneal carcinomatosis: intraoperative parameters in open (coliseum) versus closed abdomen HIPEC. Int J Surg Oncol 2015:610597","journal-title":"Int J Surg Oncol"},{"issue":"1","key":"4021_CR59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12957-017-1119-2","volume":"15","author":"C Rodriguez Silva","year":"2017","unstructured":"Rodriguez Silva C, Moreno Ruiz FJ, Bellido Estevez I, Carrasco Campos J, Titos Garcia A, Ruiz Lopez M, Gonzalez Poveda I, Toval Mata JA, Mera Velasco S, Santoyo Santoyo J (2017) Are there intra-operative hemodynamic differences between the coliseum and closed HIPEC techniques in the treatment of peritoneal metastasis? A retrospective cohort study. World J Surg Oncol 15(1):51","journal-title":"World J Surg Oncol"},{"key":"4021_CR60","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejso.2019.06.022","volume":"47","author":"S Kusamura","year":"2019","unstructured":"Kusamura S, Azmi N, Fumagalli L, Baratti D, Guaglio M, Cavalleri A, Garrone G, Battaglia L, Barretta F, Deraco M (2019) Phase Ii randomized study on tissue distribution and pharmacokinetics of cisplatin according to different levels of intra-abdominal pressure (Iap) during HIPEC. Eur J Surg Oncol 47:82\u201388","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"4021_CR61","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1245\/s10434-017-6279-3","volume":"25","author":"M Goldenshluger","year":"2018","unstructured":"Goldenshluger M, Zippel D, Ben-Yaacov A, Dux J, Yalon T, Zendel A, Rayman S, Mor E, Berkenstadt H, Fogel-Grinvald H, Ventorrero M, Nissan A (2018) Core body temperature but not intraabdominal pressure predicts postoperative complications following closed-system Hyperthermic Intraperitoneal Chemotherapy (HIPEC) administration. Ann Surg Oncol 25(3):660\u2013666","journal-title":"Ann Surg Oncol"},{"key":"4021_CR62","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.thromres.2021.06.010","volume":"204","author":"W Knoll","year":"2021","unstructured":"Knoll W, Fergusson N, Ivankovic V, Wang TF, Caiano L, Auer R, Carrier M (2021) Extended thromboprophylaxis following major abdominal\/pelvic cancer-related surgery: a systematic review and meta-analysis of the literature. Thromb Res 204:114\u2013122","journal-title":"Thromb Res"},{"issue":"1","key":"4021_CR63","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ygyno.2021.01.006","volume":"161","author":"A Chichura","year":"2021","unstructured":"Chichura A, Chambers LM, Costales AB, Yao M, Gruner M, Morton M, Rose PG, Vargas R, Michener CM, Debernardo R (2021) Impact of intra-operative factors upon peri-operative outcomes in women undergoing hyperthermic intraperitoneal chemotherapy for gynecologic cancer. Gynecol Oncol 161(1):194\u2013201","journal-title":"Gynecol Oncol"},{"issue":"2","key":"4021_CR64","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ygyno.2020.11.010","volume":"160","author":"Y Xu","year":"2021","unstructured":"Xu Y, Jia Y, Zhang Q, Du Y, He Y, Zheng A (2021) Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: systematic review and meta-analysis. Gynecol Oncol 160(2):610\u2013618","journal-title":"Gynecol Oncol"},{"issue":"1","key":"4021_CR65","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/SLA.0b013e31821b98da","volume":"254","author":"RP Merkow","year":"2011","unstructured":"Merkow RP, Bilimoria KY, Mccarter MD, Cohen ME, Barnett CC, Raval MV, Caprini JA, Gordon HS, Ko CY, Bentrem DJ (2011) Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis. Ann Surg 254(1):131\u2013137","journal-title":"Ann Surg"},{"issue":"4","key":"4021_CR66","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.jvs.2011.10.129","volume":"55","author":"RR De Martino","year":"2012","unstructured":"De Martino RR, Goodney PP, Spangler EL, Wallaert JB, Corriere MA, Rzucidlo EM, Walsh DB, Stone DH (2012) Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg 55(4):1035-1040E4","journal-title":"J Vasc Surg"},{"issue":"11","key":"4021_CR67","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s11605-008-0600-1","volume":"12","author":"D Mukherjee","year":"2008","unstructured":"Mukherjee D, Lidor AO, Chu KM, Gearhart SL, Haut ER, Chang DC (2008) Postoperative venous thromboembolism rates vary significantly after different types of major abdominal operations. J Gastrointest Surg 12(11):2015\u20132022","journal-title":"J Gastrointest Surg"},{"key":"4021_CR68","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","volume":"25","author":"HT S\u00f8rensen","year":"2000","unstructured":"S\u00f8rensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 25:1846\u20131850","journal-title":"N Engl J Med"},{"issue":"2","key":"4021_CR69","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1055\/s-2007-994925","volume":"25","author":"WR Kakkar Ak","year":"1999","unstructured":"Kakkar Ak WR (1999) Prevention of venous thromboembolism in cancer patients. Semin Thromb Hemost 25(2):239\u2013243","journal-title":"Semin Thromb Hemost"},{"issue":"Suppl 1","key":"4021_CR70","doi-asserted-by":"publisher","first-page":"S216","DOI":"10.21037\/jgo-2020-01","volume":"12","author":"NJ Carr","year":"2021","unstructured":"Carr NJ (2021) New insights in the pathology of peritoneal surface malignancy. J Gastrointest Oncol 12(Suppl 1):S216\u2013S229","journal-title":"J Gastrointest Oncol"},{"issue":"5","key":"4021_CR71","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/jth.12533","volume":"12","author":"AJ Walker","year":"2014","unstructured":"Walker AJ, West J, Card TR, Humes DJ, Grainge MJ (2014) Variation in the risk of venous thromboembolism in people with colorectal cancer: a population-based cohort study from England. J Thromb Haemost 12(5):641\u2013649","journal-title":"J Thromb Haemost"},{"issue":"21","key":"4021_CR72","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1001\/archinte.168.21.2377","volume":"168","author":"A Khorana","year":"2008","unstructured":"Khorana A, Francis C, Blumberg N, Culakova E (2008) blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med 168(21):2377\u20132381","journal-title":"Arch Intern Med"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-021-04021-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-021-04021-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-021-04021-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T09:29:13Z","timestamp":1675762153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-021-04021-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["4021"],"URL":"https:\/\/doi.org\/10.1007\/s00384-021-04021-6","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,9]]},"assertion":[{"value":"25 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Anne-Mette Hvas received speaker\u2019s fees from CSL Behring, Bayer, Boehringer-Ingelheim, Astellas and unrestricted research support from CSL Behring and Octapharma. All other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}